PMID- 36688652 OWN - NLM STAT- MEDLINE DCOM- 20230307 LR - 20230724 IS - 1098-5514 (Electronic) IS - 0022-538X (Print) IS - 0022-538X (Linking) VI - 97 IP - 2 DP - 2023 Feb 28 TI - Characterization of the HHV-6B U20 Immunoevasin. PG - e0189022 LID - 10.1128/jvi.01890-22 [doi] LID - e01890-22 AB - Roseoloviruses (human herpesvirus 6A [HHV-6A], -6B, and -7) infect >90% of the human population during early childhood and are thought to remain latent or persistent throughout the life of the host. As such, these viruses are among the most pervasive and stealthy of all viruses; they must necessarily excel at escaping immune detection throughout the life of the host, and yet, very little is known about how these viruses so successfully escape host defenses. Here, we characterize the expression, trafficking, and posttranslational modifications of the HHV6B U20 gene product, which is encoded within a block of genes unique to the roseoloviruses. HHV-6B U20 trafficked slowly through the secretory system, receiving several posttranslational modifications to its N-linked glycans, indicative of surface-expressed glycoproteins, and eventually reaching the cell surface before being internalized. Interestingly, U20 is also phosphorylated on at least one Ser, Thr, or Tyr residue. These results provide a framework to understand the role(s) of U20 in evading host defenses. IMPORTANCE The roseolovirus U20 proteins are virus-encoded integral membrane glycoproteins possessing class I major histocompatibility complex (MHC)-like folds. Surprisingly, although U20 proteins from HHV-6A and -6B share 92% identity, recent studies ascribe different functions to HHV6A U20 and HHV6B U20. HHV6A U20 was shown to downregulate NKG2D ligands, while HHV6B U20 was shown to inhibit tumor necrosis factor alpha (TNF-alpha)-induced apoptosis during nonproductive infection with HHV6B (E. Kofod-Olsen, K. Ross-Hansen, M. H. Schleimann, D. K. Jensen, et al., J Virol 86:11483-11492, 2012, https://doi.org/10.1128/jvi.00847-12; A. E. Chaouat, B. Seliger, O. Mandelboim, D. Schmiedel, Front Immunol 12:714799, 2021, https://doi.org/10.3389/fimmu.2021.714799). Here, we have performed cell biological and biochemical characterization of the trafficking, glycosylation, and posttranslational modifications occurring on HHV6B U20. FAU - Schneider, Christine L AU - Schneider CL AD - Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. FAU - Whyte, Melissa L AU - Whyte ML AD - Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. FAU - Konrad, Sheryl L AU - Konrad SL AD - Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. FAU - Hudson, Amy W AU - Hudson AW AUID- ORCID: 0000-0001-9718-6910 AD - Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. LA - eng GR - R01 GM120735/GM/NIGMS NIH HHS/United States GR - R21 AI076722/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20230123 PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Membrane Glycoproteins) RN - 0 (Viral Proteins) SB - IM MH - Humans MH - Herpesvirus 6, Human/genetics/immunology MH - *Membrane Glycoproteins/genetics/metabolism MH - *Roseolovirus Infections/immunology/virology MH - *Viral Proteins/genetics/immunology MH - Immune Evasion PMC - PMC9973003 OTO - NOTNLM OT - HHV-6A OT - HHV-6B OT - HHV-7 OT - U20 OT - herpesviruses OT - human herpesviruses OT - immune evasion COIS- The authors declare no conflict of interest. EDAT- 2023/01/24 06:00 MHDA- 2023/03/03 06:00 PMCR- 2023/07/23 CRDT- 2023/01/23 09:04 PHST- 2023/01/24 06:00 [pubmed] PHST- 2023/03/03 06:00 [medline] PHST- 2023/01/23 09:04 [entrez] PHST- 2023/07/23 00:00 [pmc-release] AID - 01890-22 [pii] AID - jvi.01890-22 [pii] AID - 10.1128/jvi.01890-22 [doi] PST - ppublish SO - J Virol. 2023 Feb 28;97(2):e0189022. doi: 10.1128/jvi.01890-22. Epub 2023 Jan 23.